The First LAMA for Inhalation Using Natural Breathing

October 8, 2020 at 12:00pm Pacific (45 minutes)

The program will review the impact of COPD in the long-term care (LTC) setting, current clinical practice recommendations to improve outcomes, and a therapy option for the treatment of COPD in the LTC setting. This promotional, non-CME program presented on behalf of Sunovion Pharmaceuticals Inc., is intended only for US health care professionals involved in the treatment of patients with COPD.
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Medical Director, Post-Acute Services & LIFE Connection/PACE
AtlantiCare/Geisinger Health System; Faculty, Thomas Jefferson University
Jefferson College of Population Health
Philadelphia, PA

Cost: FREE, Registration required.